The stock for this pharmacy chain has struggled mightily this year.With its stock trading at multiyear lows that have led to a nearly 12% dividend yield, Walgreens Boots Alliance (WBA 3.27%) has likely popped up on the radar of some value investors. As a result, some of them may be considering investing in the stock at these levels.Before making any decision on Walgreens, investors might want to look at five things regarding this company that could affect their choice.1. The stock is trading down 85% over t ...

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Walgreens Boots Alliance presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.Start slideshow: 10 Oversold Dividend ...

This eye-popping dividend yield may give you more headaches than passive income.It's tempting to gravitate toward dividend stocks that pay huge dividends. Take Walgreens Boots Alliance (WBA -0.35%) for example. The pharmacy chain's dividend yields over 11% at its current share price. In other words, investors get double-digit investment returns before factoring in any potential share price movement.However, there is never a free lunch in the stock market. It's rarely so easy.Peek behind the curtains and you ...

Last week, investors strongly contemplated that the easing of inflation, followed by the Fed’s long-awaited aggressive 50-bps rate cut on Sept.18, will provide a respite from the prolonged drab scenario within the retail pharmacy sector. While they were not wrong with respect to other industry players, Walgreens Boots’ (WBA) share price plunge, even amid the speculation of another half a percentage point cut in the rest of 2024, depicts a different story, denting investors’ enthusiasm.Since the rate cut, th ...

Walgreens stock has been a falling knife this year, but the company has levers it can pull on to strengthen its operations.Walgreens Boots Alliance (WBA -0.33%) is a highly risky stock to own right now. The pharmacy retailer has struggled with profitability, growing sales hasn't been easy, and its future is a big question mark at this point.This isn't going to be a suitable investment for most, given the risk involved. But if you're looking for a possible contrarian investment, below, I'll list the reasons ...

Class Action Lawsuit Overview - A class action lawsuit has been filed against Walgreens Boots Alliance Inc (WBA) on behalf of purchasers of its common stock between July 1 2021 and June 26 2024 [1] - Investors have until November 18 2024 to seek appointment as lead plaintiff in the lawsuit [1] Walgreens Business Operations - Walgreens operates in three business segments: US Retail Pharmacy International and US Healthcare [3] - In 2019 Walgreens announced a collaboration with VillageMD involving a $1 billion investment and expansion of primary care facilities next to Walgreens stores [3] Lawsuit Allegations - Walgreens allegedly inefficiently deployed capital meant to grow its US Healthcare segment and failed to properly implement its partnership with VillageMD [4] - The company was unable to profitably scale VillageMD and its rollout of clinics did not proceed as planned [4] - Walgreens built too many VillageMD clinics leading to understaffing and fewer patients which slowed the growth of its US Healthcare segment [4] - Executives failed to manage investor expectations about the negative impact of the VillageMD rollout on short-term profits and exaggerated VillageMD's value [4] Financial Performance and Stock Price Impact - On June 27 2023 Walgreens announced disappointing earnings for fiscal Q3 2023 reduced 2023 guidance and revealed slower profit ramp for US Healthcare due to VillageMD's underperformance causing a $2 95 (9 3%) drop in stock price [5] - On July 27 2023 the departure of the CFO caused a $0 83 (nearly 3%) drop in stock price [5] - On September 1 2023 the departure of the CEO caused a $1 88 (7 4%) drop in stock price [5] - On January 4 2024 disappointing fiscal Q1 2024 results attributed to VillageMD operations caused a $1 31 (5%) drop in stock price [6] - On June 27 2024 disappointing fiscal Q3 2024 results and announcement of reducing stake in VillageMD caused a $3 47 (22%) drop in stock price [6] Legal Representation - DiCello Levitt is handling the class action lawsuit and has achieved top recognition as Plaintiffs Firm of the Year and Trial Innovation Firm of the Year [7][8]

The most recent trading session ended with Walgreens Boots Alliance (WBA) standing at $9.01, reflecting a -0.55% shift from the previouse trading day's closing. The stock trailed the S&P 500, which registered a daily loss of 0.29%. At the same time, the Dow lost 0.25%, and the tech-heavy Nasdaq lost 0.31%.Coming into today, shares of the largest U.S. drugstore chain had lost 15.56% in the past month. In that same time, the Retail-Wholesale sector gained 4.15%, while the S&P 500 gained 1.57%.Investors will b ...

BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Saxena White P.A. has filed a securities fraud class action lawsuit (the “Class Action”) in the United States District Court for the Northern District of Illinois against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) and certain of its executive officers (collectively, “Defendants”). The Class Action asserts claims under Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 (the “Exchange Act”) and U.S. Securiti ...

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on behalf of long-term stockholders following a class action complaint that was filed against Walgreens on July 12, 2024 with a Class Period from October 12, 2023 to June 26, 2024. Our investigation concerns whether the board of directors of Walgreens have breached their fiduciary duties to the co ...

It could be smaller, but more financially sustainable if things go as planned.While you've probably had a consistent experience going to the pharmacies operated by Walgreens Boots Alliance (WBA 4.19%) over the years, that doesn't make it a company that's in stasis. In fact, within the next three years, there's a very high chance that it'll be changing in a handful of ways that are relevant to investors.But even if the retail experience doesn't shift much, there's reason to believe that the stock's value wil ...